Literature DB >> 22496234

Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections.

Natasha Malik-Soni1, Lori Frappier.   

Abstract

The Epstein-Barr nuclear antigen 1 (EBNA1) protein of Epstein-Barr virus (EBV) is expressed in both latent and lytic modes of EBV infection and contributes to EBV-associated cancers. Using a proteomics approach, we profiled EBNA1-host protein interactions in nasopharyngeal and gastric carcinoma cells in the context of latent and lytic EBV infection. We identified several interactions that occur in both modes of infection, including a previously unreported interaction with nucleophosmin and RNA-mediated interactions with several heterogeneous ribonucleoproteins (hnRNPs) and La protein.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496234      PMCID: PMC3393576          DOI: 10.1128/JVI.00194-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Messenger-RNA-binding proteins and the messages they carry.

Authors:  Gideon Dreyfuss; V Narry Kim; Naoyuki Kataoka
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

Review 2.  The La protein.

Authors:  Sandra L Wolin; Tommy Cedervall
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Epstein-Barr virus nuclear antigen 1 is a DNA-binding protein with strong RNA-binding activity.

Authors:  Chih-Chung Lu; Chia-Wei Wu; Shin C Chang; Tzu-Yi Chen; Chwan-Ren Hu; Ming-Yi Yeh; Jen-Yang Chen; Mei-Ru Chen
Journal:  J Gen Virol       Date:  2004-10       Impact factor: 3.891

4.  Reconstitution of Epstein-Barr virus-based plasmid partitioning in budding yeast.

Authors:  P Kapoor; K Shire; L Frappier
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

5.  An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma.

Authors:  Y Sun; G Hegamyer; Y J Cheng; A Hildesheim; J Y Chen; I H Chen; Y Cao; K T Yao; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 6.  Epstein-Barr virus in the pathogenesis of NPC.

Authors:  Nancy Raab-Traub
Journal:  Semin Cancer Biol       Date:  2002-12       Impact factor: 15.707

7.  Sequential Peptide Affinity (SPA) system for the identification of mammalian and bacterial protein complexes.

Authors:  Mahel Zeghouf; Joyce Li; Gareth Butland; Anna Borkowska; Veronica Canadien; Dawn Richards; Bryan Beattie; Andrew Emili; Jack F Greenblatt
Journal:  J Proteome Res       Date:  2004 May-Jun       Impact factor: 4.466

8.  Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.

Authors:  Melissa N Holowaty; Mahel Zeghouf; Hong Wu; Judy Tellam; Vicki Athanasopoulos; Jack Greenblatt; Lori Frappier
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

9.  Isolation and characterization of the genes for two small RNAs of herpesvirus papio and their comparison with Epstein-Barr virus-encoded EBER RNAs.

Authors:  J G Howe; M D Shu
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins.

Authors:  D K Snudden; J Hearing; P R Smith; F A Grässer; B E Griffin
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

View more
  24 in total

1.  Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.

Authors:  Italo Tempera; Alessandra De Leo; Andrew V Kossenkov; Matteo Cesaroni; Hui Song; Noor Dawany; Louise Showe; Fang Lu; Priyankara Wikramasinghe; Paul M Lieberman
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

Review 2.  The Promise of Proteomics in the Study of Oncogenic Viruses.

Authors:  Alison A McBride
Journal:  Mol Cell Proteomics       Date:  2017-01-19       Impact factor: 5.911

Review 3.  Elucidation of host-pathogen protein-protein interactions to uncover mechanisms of host cell rewiring.

Authors:  Charlotte Nicod; Amir Banaei-Esfahani; Ben C Collins
Journal:  Curr Opin Microbiol       Date:  2017-08-11       Impact factor: 7.934

4.  Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.

Authors:  Sheila Mansouri; Qun Pan; Benjamin J Blencowe; Julie M Claycomb; Lori Frappier
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

Review 5.  RNA families in Epstein-Barr virus.

Authors:  Walter N Moss; Nara Lee; Genaro Pimienta; Joan A Steitz
Journal:  RNA Biol       Date:  2013-12-20       Impact factor: 4.652

6.  A proteomic approach to discover and compare interacting partners of papillomavirus E2 proteins from diverse phylogenetic groups.

Authors:  Moon Kyoo Jang; D Eric Anderson; Koenraad van Doorslaer; Alison A McBride
Journal:  Proteomics       Date:  2015-04-28       Impact factor: 3.984

7.  Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.

Authors:  Umama Z Siddiqi; Anup S Vaidya; Xinliu Li; Edyta Marcon; Sai Wah Tsao; Jack Greenblatt; Lori Frappier
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

8.  Flavivirus Infection Impairs Peroxisome Biogenesis and Early Antiviral Signaling.

Authors:  Jaehwan You; Shangmei Hou; Natasha Malik-Soni; Zaikun Xu; Anil Kumar; Richard A Rachubinski; Lori Frappier; Tom C Hobman
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

9.  Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein.

Authors:  Natasha Malik-Soni; Lori Frappier
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

10.  Identification of a novel protein interaction motif in the regulatory subunit of casein kinase 2.

Authors:  Jennifer Yinuo Cao; Kathy Shire; Cameron Landry; Gerald D Gish; Tony Pawson; Lori Frappier
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.